Orchid Pharma lists 4.45 crore equity shares on NSE and BSE
- Orchid Pharma listed 4,45,86,052 equity shares on NSE and BSE from September 23, 2026
- Shares were allotted under a scheme of amalgamation approved by the NCLT, Chennai Bench
- The company filed intimation under Regulation 30 of SEBI Listing Regulations
*this image is generated using AI for illustrative purposes only.
Orchid Pharma Limited listed 4,45,86,052 equity shares on the National Stock Exchange of India (NSE) and BSE Limited from September 23, 2026. This listing follows the allotment of shares pursuant to a scheme of amalgamation sanctioned by the National Company Law Tribunal (NCLT), Chennai Bench.
The company issued an intimation under Regulation 30 of the SEBI Listing Regulations to both exchanges. The filing confirmed that the equity shares have been admitted to dealings effective from the specified date.
Regulatory compliance and allotment details
The allotment was executed in continuation of an earlier intimation dated August 1, 2026. The company cited SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, as part of its regulatory framework for this disclosure.
Kapil Dayya, Company Secretary and Compliance Officer, signed the digital submission confirming the listing status for both exchanges.
Listing summary
| Detail | Information |
|---|---|
| Number of shares | 4,45,86,052 |
| Listing date | September 23, 2026 |
| Exchanges | NSE, BSE |
| Authority | NCLT, Chennai Bench |
| Basis | Scheme of Amalgamation |
Historical Stock Returns for Orchid Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.47% | +11.52% | +9.98% | +106.94% | +43.81% | +164.69% |
How will the increased share count from the amalgamation impact Orchid Pharma's future earnings per share (EPS) dilution?
What are the expected synergies and cost-saving targets resulting from the NCLT-sanctioned scheme of amalgamation?
Will the listing of these shares trigger any immediate changes in index inclusion or institutional holding limits for Orchid Pharma?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
